scholarly article | Q13442814 |
P2093 | author name string | Maguire HC Jr | |
Weiner DB | |||
Greene MI | |||
Lodato RF | |||
LiVolsi VA | |||
P433 | issue | 4 | |
P921 | main subject | immunohistochemistry | Q899285 |
Atypical ductal hyperplasia | Q4818889 | ||
ductal carcinoma | Q5311598 | ||
P304 | page(s) | 449-454 | |
P577 | publication date | 1990-07-01 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast | |
P478 | volume | 3 |
Q37265571 | Apocrine adenosis: a precursor of aggressive breast cancer? |
Q35671149 | Biological features of premalignant disease in the human breast |
Q40848953 | Biological indices in the assessment of breast cancer |
Q40684734 | Current management of carcinoma of the breast |
Q33642507 | Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes |
Q92015590 | Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers |
Q89879114 | HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies |
Q26780318 | HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach |
Q91728336 | HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis |
Q35775640 | Identification of genes expressed in premalignant breast disease by microscopy-directed cloning |
Q41710798 | Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors |
Q71989512 | MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo |
Q35782037 | Molecular analysis of premalignant and carcinoma in situ lesions of the human breast |
Q28363615 | Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53 |
Q37020386 | Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood |
Q41659124 | Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component |
Q35096055 | Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma |
Q36434480 | The enigmatic nature of apocrine breast lesions |
Q37326072 | The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies |
Q38673589 | When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase |
Q37119722 | c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma |
Search more.